EBD Group is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Former CEO; Board Member at Genzyme; Aura Biosciences
Henri A. Termeer, former CEO, Chairman and President of Genzyme Corporation. Mr. Termeer was appointed president of Genzyme in 1983 became its chief executive officer in 1985 and chairman in 1988. He retired from Genzyme in June 2011 following the acquisition of Genzyme by Sanofi in a transaction valued at more than $20 billion. Mr. Termeer is a Board member of Massachusetts Institute of Technology Corporation and serves on its Executive Committee, a director of Massachusetts General Hospital, board member of Partners HealthCare and a member of the Board of Fellows of Harvard Medical School. He sits on the boards of Biotechnology Innovation Organization (BIO), New England Healthcare Institute (NEHI), Boston Ballet, Museum of Science and WGBH. He also serves on the boards of Abiomed, Inc., AVEO Pharmaceuticals, Moderna Therapeutics and ProQR Therapeutics. Mr. Termeer studied economics at the Economische Hogeschool (Erasmus University, The Netherlands) and earned an MBA from the Darden Business School at the University of Virginia.